177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
Clinical trial NCT04689828 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04689828
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2022-10-02
- Enrollment
- 469
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.